Table 1.
Characteristics of enrolled patients.
| Eradicated | Not-Eradicated | ||
|---|---|---|---|
| Number of patients | 98 (61.2%) | 62 (38.8) | 160 |
| Males | 60 | 33 | 93 (58.1%) |
| Females | 38 | 29 | 67 (41.9%) |
| Age (median, IQR) | 64 (55–74) | 57.5 (46.2–71.7) | 61.5 (52–73) years |
| BMI (median, IQR) | 24.9 (22.8–26.6) | 24.1 (21.8–26.8) | 24.6 (22.5–26.6) kg/m2 |
| Fibroscan liver stiffness (median, IQR) | 10.2 (6.9–17.8) | 7 (5.8–9.3) | 8.2 (6.3–14.9) kPa |
| 2D SWE liver stiffness (median, IQR) | 8.1 (5.4–14.7) | 6.8 (5.6–8.8) | 7.3 (5.6–12.3) kPa |
| AST (median, IQR) | 20.5 (17–28.7) | 35.6 (33–55.2) | 27 (19–35.2) U/L |
| ALT (median, IQR) | 19 (14–25.7) | 43.5 (39.6–72.2) | 24.5 (16–41.5) U/L |
| Total bilirubin (median, IQR) | 0.6 (0.5–0.8) | 0.7 (0.7–0.9) | 0.7 (0.5–0.9) mg/dL |
| GGT (median, IQR) | 24.5 (17–41.8) | 42.1 (27–58) | 31 (19–42.1) U/L |
| PLT (mean ± SD) | 173.8 ± 61.4 | 187.1 ± 46.5 | 179 ± 56.3 × 109/mcL |
| Albumin (median, IQR) | 4.1 (4–4.3) | 4.1 (4–4.2) | 4.1 (4–4.2) g/dL |
| INR (median, IQR) | 1.03 (0.99–1.06) | 1.04 (0.99–1.04) | 1.04 (0.99–1.04) |
| Child–Pugh class | |||
| A5 | 89 (90.8%) | 56 (90.3%) | 145 (90.6%) |
| A6 | 9 (9.2%) | 6 (9.7%) | 15 (9.4%) |
| Diabetes | 17 (17.3%) | 7 (11.3%) | 24 (15%) |
| Obesity | 10 (10.2%) | 8 (12.9%) | 18 (11.2%) |